Discover
ANGO
AngioDynamics, Inc.
13.08
2 x 9.39
2 x 16.64
bid
ask
+
0.07
0.54%
2 @ 04:00 PM
13.08 +0.00 (0.00%)
| Ytd | 1.87% | |
| 1y | 37.39% |
12.99
day range
13.28
8.36
52 week range
13.99
| Open | 13.04 | Prev Close | 13.01 | Low | 12.99 | High | 13.28 | Mkt Cap | 540.45M |
| Vol | 350.52K | Avg Vol | 387.06K | EPS | -0.76 | P/E | N/A | Forward P/E | -36.21 |
| Beta | 0.67 | Short Ratio | 2.88 | Inst. Own | 81.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 11.68 | 200-d Avg | 11.49 | 1yr Est | 13.00 |
| Income Statement | |||
| Total Revenue | 78.42M | ||
| Revenues (USD) | 78.42M | ||
| Cost of Revenue | 36.94M | ||
| Gross Profit | 41.48M | ||
| Operating Expenses | 54.43M | ||
| Research and Development Expense | 7.08M | ||
| Selling, General and Administrative Expense | 38.16M | ||
| Operating Income | -12.95M | ||
| Interest Expense | 88.00K | ||
| Income Tax Expense | 12.00K | ||
| Net Income | -8.08M | ||
| Net Income Common Stock | -8.08M | ||
| Net Income Common Stock (USD) | -8.08M | ||
| Consolidated Income | -8.08M | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -7.98M | ||
| Earning Before Interest & Taxes (USD) | -7.98M | ||
| Weighted Average Shares | 41.60M | ||
| Weighted Average Shares Diluted | 41.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 37.81M | ||
| Cash and Equivalents (USD) | 37.81M | ||
| Trade and Non-Trade Receivables | 45.55M | ||
| Current Assets | 155.55M | ||
| Property, Plant & Equipment Net | 29.14M | ||
| Total Assets | 260.68M | ||
| Current Liabilities | 66.07M | ||
| Total Liabilities | 87.32M | ||
| Accumulated Retained Earnings (Deficit) | -454.53M | ||
| Accumulated Other Comprehensive Income | 2.71M | ||
| Shareholders Equity | 173.36M | ||
| Shareholders Equity (USD) | 173.36M | ||
| Assets Non-Current | 105.13M | ||
| Goodwill and Intangible Assets | 65.49M | ||
| Inventory | 58.58M | ||
| Liabilities Non-Current | 21.26M | ||
| Trade and Non-Trade Payables | 29.11M | ||
| Tax Liabilities | 4.55M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.94M | ||
| Net Cash Flow from Financing | 621.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.83M | ||
| Capital Expenditure | -1.51M | ||
| Issuance (Purchase) of Equity Shares | 716.00K | ||
| Issuance (Repayment) of Debt Securities | -95.00K | ||
| Net Cash Flow from Investing | -1.51M | ||
| Net Cash Flow from Operations | -3.11M | ||
| Effect of Exchange Rate Changes on Cash | 168.00K | ||
| Share Based Compensation | 2.68M | ||